Navigation Links
BioCis Pharma Reports Positive Phase IIa Clinical Results in Atopic Dermatitis
Date:7/3/2009

TURKU, Finland, July 3 /PRNewswire/ -- BioCis Pharma Ltd., a privately held drug development company with its headquarters in Turku, Finland, announced positive results from its Phase IIa clinical trial of ProtoCure(TM) emulsion cream, the company's novel topical drug for dermatology. This double-blind, placebo-controlled study, conducted in Finland, included 13 patients with mild to moderate atopic dermatitis who applied the ProtoCure emulsion cream to the affected skin areas twice daily for up to four weeks. The objectives were to evaluate the tolerability, pharmacokinetics, and efficacy of the topical treatment.

Study results showed excellent safety profile, and no serious adverse events were reported during the study. No patient dropped out due to adverse side effects of the treatment. Pharmacokinetic analyses showed no systemic exposure to the active ingredient of the product. Efficacy was assessed by performing instrumental measurements of skin lesion redness (erythema) and skin barrier function by trans-epidermal water loss (TEWL) during the 28-day period. Physician assessments, such as Eczema Area and Severity Index (EASI) were also evaluated. ProtoCure emulsion cream was superior to placebo in decreasing skin redness and improving skin barrier function. Statistically significant improvement was observed as early as day 10 after begining treatment. There was also a significant improvement in EASI score over the whole treatment period for ProtoCure emulsion cream as a sign of positive treatment effect. The EASI score difference did not reach statistical significance when compared to placebo, mainly due to the small number of patients studied.

"We are very pleased with the promising results of this study," says Lasse Leino, CEO of BioCis Pharma. "Skin barrier dysfunction is now recognized as a hallmark feature of atopic dermatitis. Any drug showing capacity for restoring this disturbance has signi
'/>"/>

SOURCE BioCis Pharma Ltd
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. BioCis Pharma Starts a Phase I Clinical Trial With a New Cancer Drug
2. Pangu BioPharma, aTyr Pharmas Subsidiary in Hong Kong, Files Three Patent Applications
3. King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Therapeutic Use
4. Jazz Pharmaceuticals and UCB Announce Second Phase III Study of Sodium Oxybate in Patients With Fibromyalgia Meets Primary Endpoints
5. Conatus Pharmaceuticals Initiates a Second Phase 2 Clinical Trial for the Treatment of Hepatitis
6. Covance Announces Integrated Radiolabeled Clinical Pharmacology Studies
7. CeNeRx BioPharma Obtains Rights to Novel Drug Candidate for Prevention and Treatment of Neurodegeneration Disorders
8. VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA-2291 and Phase 3 Outcome Trial in Cardiovascular Disease
9. Oramed Pharmaceuticals to Present at the 8th National Life Science & Technology Week ILSI -BIOMED Conference, Israel 2009
10. Merz Pharmaceuticals Announce Three Studies of NT-201 - (Botulinum neurotoxin type A Free From Complexing Proteins)
11. DOR BioPharma Receives EMEA Agreement on the Design of its Confirmatory Phase 3 Clinical Trial of orBec(R) in GI GVHD

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)... ,, NEWYORK,Nov.23/PRNewswire/--Reportlinker...leinitscatalogue. ,, SterilizationSystems&.../www.reportlinker.com/p0164340/Sterilization-Syste...tm_source=prnewswire&utm_medium=pr&utm_cam...nuestobethemostimportantandwidelyusedprocedure.Ste...
(Date:11/23/2009)... ,, MINNEAPOLIS,Nov.23/PRNewswire/--BridgePo...rk(ConformiteEuropeene)foritscoronaryandperipheral...ftheCrossBoss(TM)CTOCrossingCatheterandtheStingray...iesofinterventionalcathetersthataredesignedtonavig...restorationviaangioplastyandstenting. ,, TheNat...
(Date:11/23/2009)... ,, THEWOODLANDS,Texas,Nov.23/PRNewswire-Fir...X ),announcedtodaythattop-linedatafromitsPhase2cli...ngirritablebowelsyndrome(IBS)willbepresentedatGAST...owedasignificantimprovementinIBSsymptoms,willbepre...identofclinicaldevelopment,onNovember25,2009at2:30...
Breaking Medicine Technology:Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 2Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 3Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 4Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 5Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 6Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 7BridgePoint Medical(R) Receives European CE Mark for Stingray(R) and CrossBoss(TM) for Opening Completely Blocked Arteries 2Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 2Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 3Body Clock Blood Sugar Control Seem Linked 59234 1Body Clock Blood Sugar Control Seem Linked 59234 2KEAP1 Keeps major cancer promoting protein at bay 59230 1KEAP1 Keeps major cancer promoting protein at bay 59230 2Face Masks for Patients May Leak Spread Germs 59226 1Face Masks for Patients May Leak Spread Germs 59226 2
...ly Detection of Alzheimer,s and Parkinson,s Diseas...mic, Inc. (OTC Bulletin Board: TBIO) and Power3 Me...day announced they have finalized a transaction, p... December 2, 2008 (see "Transgenomic Signs Letter ...th Option to Acquire Power3 Medical Products, Neur...
... Men who experience erectile dysfunction between t...p heart disease than men without dysfunction, acco...s also found that men with erectile dysfunction ha... , "The highest risk for coronary heart disease wa...uver, Ph.D. The study was published in the Februar...
Other Medicine Technology:Transgenomic and Power3 Medical Complete Agreement for Exclusive License of Neurodegenerative Biomarker Test 2Transgenomic and Power3 Medical Complete Agreement for Exclusive License of Neurodegenerative Biomarker Test 3Transgenomic and Power3 Medical Complete Agreement for Exclusive License of Neurodegenerative Biomarker Test 4Mayo Clinic Study Finds Younger Men With Erectile Dysfunction at Double Risk of Heart Disease 2Mayo Clinic Study Finds Younger Men With Erectile Dysfunction at Double Risk of Heart Disease 3
(Date:11/23/2009)...tedConcordiaDental,oneofthenation,slargestdentalin...unitedconcordia.comwhichprovidesimprovedaccesstoin.... ,, "Thesiteboastsacleandesign,betterorganizat...itorsfindinformationquicklyandeasily,"saidPaulJone...."Fresh,relevantcontent,coupledwithanimprovedeaseo...
(Date:11/23/2009)...ade,M.D.announcesthenewlyenhancedCyberKnifeequipme...fMiami,( www.cyberknifemiami.com ). ,, TheCyb...sedoseofradiationthatkillscancercellswithnoinvasiv...om30minutestoonehour,andisusuallycompletedin1-5tre...intheSoutheasternU.S.,theMiamifacilityhasledtheway...
(Date:11/23/2009)...al and physical health , , MONDAY, Nov. ...as many years off your life as smoking does, a new...pression and anxiety appears to be better for long...to their conclusions after analyzing death records...he four years after the survey, the death rate was...
(Date:11/23/2009)...ovember issue of GIE: Gastrointestinal Endoscopy ...the American Society for Gastrointestinal Endoscop... that Barrett,s esophagus was detected in six perc...reening. Also in this issue, two studies examined ...ce, in the largest single-center experience to dat...
(Date:11/23/2009)...ystem study has found that one out of five Type 2 ...ounds or more overweight. , Researchers reported...etes are obese, and 20.7 percent are morbidly obes...tes, 1 in 3 is morbidly obese. , "The rate of mo...ing at a very alarming rate, and this has substant...
Breaking Medicine News(10 mins):Health News:Depression May Up Death Risk to That of Smoking 2Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 2Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 3Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 4Health News:Study highlights from November issue of GIE: Gastrointestinal Endoscopy 5Health News:Diabetics show alarming increase in morbid obesity 2
...d of protection against bird flu has been studied ...at the University of Rochester. // This involves a...emic of bird flu hits, it would take months to dev...accination. An initial dose of the vaccine is give...
...st advanced nations of the world today, Britain ha...e most 'obese nation in Europe' last week. //In a ... more than one –fourth of the nation's population ...ards improving people's quality of life through go...
...rds today throughout the country are 'Dengue' an...brought on by the bite of an infected// Aedes aeg...olling in several Indian states. Dengue is the m...ning to go out of hand unless a formidable solutio...
...eople have died of dengue fever in the Dominican R... the health authorities announced a drop in the nu...al patients hit by the disease this year is nearly...ojas said a large number of student volunteers wil...
...avels that other factors play a strong role along ...Down's Syndrome.// Many older women who have been ...ound out that they are pregnant often find themsel...us (unborn developing baby) being malformed or men...
...rs at the Launceston General Hospital have develop... According to the director of the LGH Dementia Res...luid from the brain can treat one type of dementia... and women of the age 58-92 years, from the hospit...
Other Medicine News:Health News:Dengue and Chikungunya: The Dirge of a Nation 2Health News:Dengue and Chikungunya: The Dirge of a Nation 3Health News:Dengue and Chikungunya: The Dirge of a Nation 4Health News:Cause of ‘Down Syndrome’ cannot be pinned down to maternal age alo 2
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
... reference laboratory and a worldwide leader in in... offers an extensive test menu of highly complex a...athology. Owned by the University of Utah, ARUP La...nation's university teaching hospitals and childre...
Medicine Products: